A new research paper was published in Volume 16 of Oncotarget on October 6, 2025, titled "ACTM-838, a novel systemically delivered bacterial...
Vous n'êtes pas connecté
Researchers have developed a new nanomedicine therapy that delivers anticancer drugs to lung cancer cells and enhances the immune system’s ability to fight cancer. The team at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, showed promising results for the new therapy in cancer cells in the lab and in mouse lung tumour [...]
A new research paper was published in Volume 16 of Oncotarget on October 6, 2025, titled "ACTM-838, a novel systemically delivered bacterial...
Metastatic cancer, where cancer spreads to other parts of the body, is the main reason people die from cancer. While doctors understand how cancer...
In a promising new step toward better cancer treatments, researchers in France have found a way to help the immune system attack and destroy certain...
In a promising new step toward better cancer treatments, researchers in France have found a way to help the immune system attack and destroy certain...
The most common type of liver cancer in children, hepatoblastoma, surprisingly appears to contain many immune cells from a type that has long been...
Scientists at the Fralin Biomedical Research Institute at VTC and their collaborators are exploring emerging trends in cancer immunotherapy, with...
One of the newest weapons that scientists have developed against cancer is a type of engineered immune cell known as CAR-NK (natural killer) cells....
DUBLIN--(BUSINESS WIRE)--The "CD47 Inhibitors Drug Market Opportunity, Clinical Application by Indications & Clinical Trials Insight 2026" report...
This year's Nobel Prize in Physiology or Medicine has been awarded to three scientists for their research on regulatory T cells (Tregs). The discovery...
This year's Nobel Prize in Physiology or Medicine has been awarded to three scientists for their research on regulatory T cells (Tregs). The discovery...